Quick Answer
Shuttle Pharmaceuticals Holdings, Inc. reported Total Assets of $10.48 million for fiscal year 2025.
Shuttle Pharmaceuticals Holdings, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $10.48M | +318.0% |
| 2024 | $2.51M | -57.9% |
| 2023 | $5.95M | -31.2% |
| 2022 | $8.65M | +1228.0% |
| 2021 | $651.6K | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $3.54M | +426.0% | -35.6% |
| June 30, 2025 | $5.50M | +95.7% | +3.7% |
| March 31, 2025 | $5.31M | +11.7% | +111.9% |
| December 31, 2024 | $2.51M | -57.9% | +272.1% |
| September 30, 2024 | $673.6K | -90.9% | -76.1% |
| June 30, 2024 | $2.81M | -68.2% | -40.8% |
| March 31, 2024 | $4.75M | -54.4% | -20.1% |
| December 31, 2023 | $5.95M | -31.2% | -19.3% |
- Shuttle Pharmaceuticals Holdings, Inc. showed an increase of +318.0% in Total Assets compared to the prior fiscal year.
- Over the 2021–2025 period, Shuttle Pharmaceuticals Holdings, Inc.’s total assets has grown by 1507.6% (from $651.6 thousand to $10.48 million).
- The most recent figure is from Shuttle Pharmaceuticals Holdings, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: